Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’S Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details OF Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country wise Market estimation using bottom up approach
1.6.1.3 Approach 3: Country wise Market estimation using top down approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 Key KoL Responses
1.10 Market Share Calculations
1.11 List of Secondary Sources
1.12 Objectives
1.12.1 Objective 1
1.12.2 Objective 2
1.13 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Actinic Keratosis Treatment Market – Industry Outlook
3.1 Market Lineage Outlook
3.1.1 Parent Market Lineage Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Drivers
3.3.1.1 Increasing prevalence of actinic keratosis coupled with rising geriatric population
3.3.1.2 Rising awareness among people and presence of robust treatment options
3.3.2 Market Restraints Analysis
3.3.2.1 Availability of generic preparations
3.3.2.2 Side effects associated with the drug treatment
3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.5 Industry Analysis – Porter’s
3.6 Reimbursement & Regulatory Scenario
3.7 Major Deals & Strategic Alliances
3.7.1 NEW Product Launch
3.7.2 Acquisition
3.7.3 Expansion
3.7.4 Partnership
3.7.5 Marketing & Promotions
3.7.5.1 Market entry strategies
3.7.9 Consumer Behavior Analysis
Chapter 4 Actinic Keratosis Treatment Market Analysis: Therapy Scope, 2018 – 2030 (Revenue, USD Million)
4.1 Actinic Keratosis Treatment Market: Therapy Movement Analysis
4.2 Surgery
4.2.1 Surgery Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.3 Topical
4.3.1 Topical Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.4 Photodynamic Therapy
4.4.1 Photodynamic Therapy Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 5 Actinic Keratosis Treatment Market Analysis: Drug Class Scope, 2018 – 2030 (Revenue, USD Million)
5.1 Actinic Keratosis Treatment Market: Drug Class Movement Analysis
5.2 Nucleoside Metabolic Inhibitor
5.2.1 Nucleoside Metabolic Inhibitor Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.3 NSAIDs
5.3.1 NSAIDS Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.4 Immune Response Modifiers
5.4.1 Immune Response Modifiers Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.5 Photoenhancers
5.5.1 Photoenhancers Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.6 Photoenhancers
5.6.1 Photoenhancers Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 6 Actinic Keratosis Treatment Market Analysis: End-use Scope, 2018 – 2030 (Revenue, USD Million)
6.1 Actinic Keratosis Treatment Market: End-use Movement Analysis
6.2 Hospitals
6.2.1 Hospitals Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.3 Private Clinics
6.3.1 Private Clinics Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.4 Homecare
6.4.1 Homecare Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.5 Others
6.5.1 Others Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 7 Actinic Keratosis Treatment Market Analysis, Regional Scope, 2018 – 2030, (Revenue, USD Million)
7.1 Market Share Analysis by Region, 2021 & 2030
7.1.1 North America
7.1.1.1 North America Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.1.1.2 U.S.
7.1.1.2.1 U.S. Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.1.1.3 Canada
7.1.1.3.1 Canada Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.1.2 Europe
7.1.2.1 Europe Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.1.2.2 U.K.
7.1.2.2.1 U.K. Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.1.2.3 Germany
7.1.2.3.1 Germany Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.1.2.4 France
7.1.2.4.1 France Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.1.2.5 Italy
7.1.2.5.1 Italy Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.1.2.6 Spain
7.1.2.6.1 Spain Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.1.3 Asia-Pacific
7.1.3.1 Asia-Pacific Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.1.3.2 Japan
7.1.3.2.1 Japan Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.1.3.3 China
7.1.3.3.1 China Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.1.3.4 India
7.1.3.4.1 India Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.1.3.5 South Korea
7.1.3.5.1 South Korea Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.1.3.6 Australia
7.1.3.6.1 Australia Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.1.4 Latin America
7.1.4.1 Latin America Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.1.4.2 Brazil
7.1.4.2.1 Brazil Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.1.4.3 Mexico
7.1.4.3.1 Mexico Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.1.4.4 Argentina
7.1.4.4.1 Argentina Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.1.5 Middle East And Africa
7.1.5.1 Middle East & Africa Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.1.5.2 South Africa
7.1.5.2.1 South Africa Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.1.5.3 Saudi Arabia
7.1.5.3.1 Saudi Arabia Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.1.5.4 UAE
7.1.5.4.1 UAE Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 8 Actinic Keratosis Treatment Market: Competitive Analysis
8.1 Recent Developments and Impact Analysis, by Key Market Participants
8.1.1 Ansoff Matrix
8.2 Company Categorization
8.2.1 Innovators
8.2.1.1 Market Differentiators
8.3 Vendor Landscape
8.3.1 List Of Key Distributors And Channel Partners
8.3.2 Key Customers
8.3.3 Key Company Market Share Analysis, 2021
8.4 Public Companies
8.4.1 Competitive Dashboard Analysis
8.5 Private Companies
8.5.1 List Of Key Emerging Companies
8.6 Regional Network Map
8.7 Key Regional/Local Competitors for actinic keratosis treatment in Japan, Australia, Korea, India, Singapore, and Europe
8.8 Company Profiles
8.8.1 ALMIRALL S.A.
8.8.1.1 Company overview
8.8.1.2 Financial performance
8.8.1.3 Product benchmarking
8.8.1.4 Strategic initiatives
8.8.2 LEO PHARMA A/S
8.8.2.1 Company overview
8.8.2.2 Financial performance
8.8.2.3 Product benchmarking
8.8.2.4 Strategic initiatives
8.8.3 SUN PHARMACEUTICAL INDUSTRIES LTD.
8.8.3.1 Company overview
8.8.3.2 Financial performance
8.8.3.3 Product benchmarking
8.8.3.4 Strategic initiatives
8.8.4 NOVARTIS AG
8.8.4.1 Company overview
8.8.4.2 Financial performance
8.8.4.3 Product benchmarking
8.8.4.4 Strategic initiatives
8.8.5 GALDERMA
8.8.5.1 Company overview
8.8.5.2 Affymetrix
8.8.5.3 Company overview
8.8.5.4 Financial performance
8.8.5.5 Product benchmarking
8.8.5.6 Strategic initiatives
8.8.6 ORTHO DERMATOLOGICS (BAUSCH HEALTH COMPANIES INC.)
8.8.6.1 Company overview
8.8.6.2 Financial performance
8.8.6.3 Product benchmarking
8.8.6.4 Strategic initiatives
8.8.7 BIOFRONTERA AG
8.8.7.1 Company overview
8.8.7.2 Financial performance
8.8.7.3 Product benchmarking
8.8.7.4 Strategic initiatives
8.8.8 HILL PHARMACEUTICALS, INC.
8.8.8.1 Company overview
8.8.8.2 Financial performance
8.8.8.3 Product benchmarking
8.8.8.4 Strategic initiatives